In a major win for the scientific community, Google DeepMind has announced significantly expanded access to AlphaFold 3. The model, which can predict the structure and interactions of all life’s molecules with unprecedented accuracy, is now freely available to non-commercial researchers worldwide.

While its predecessor revolutionized protein prediction, AlphaFold 3 goes much further. It models the interactions between proteins, DNA, RNA, and small molecules (drugs). This capability is crucial for understanding the biological mechanisms of disease and designing new therapeutics.

Access is provided through the new AlphaFold Server, giving biophysicists and drug discovery researchers a powerful interface to run predictions without needing massive computational resources. This democratization of "digital biology" is expected to accelerate breakthroughs in fields ranging from cancer research to sustainable agriculture.

The ability to predict how a drug molecule binds to a protein target in seconds—rather than months of lab work—is a game changer. Pharmaceutical companies (via commercial licenses) and academic labs can now iterate on drug candidates at the speed of software, potentially shaving years off the drug development timeline.